Publications

SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancement.

Wang YT, Allen RD 3rd, Kim K, Shafee N, Gonzalez AJ, Nguyen MN, Valentine KM, Cao X, Lu L, Pai CI, Johnson S, Kerwin L, Zhou H, Zhang Y, Shresta S.

The ability of Zika virus intravenous immunoglobulin to protect from or enhance Zika virus disease.

Pinto AK, Hassert M, Han X, Barker D, Carnelley T, Branche E, Steffen TL, Stone ET, Geerling E, Viramontes KM, Nykiforuk C, Toth D, Shresta S, Kodihalli S, Brien JD.

Emergence of a novel dengue virus 3 (DENV-3) genotype-I coincident with increased DENV-3 cases in Yangon, Myanmar between 2017 and 2019.

Soe AM, Ngwe Tun MM, Nabeshima T, Myat TW, Htun MM, Lin H, Hom NS, Inoue S, Nwe KM, Aye LPP, Fukuta M, Thant KZ, Hasebe F, Morita K, Shresta S, Thu HM, Moi ML.

Animal models for SARS-Cov2/Covid19 research-A commentary.

Jarnagin K, Alvarez O, Shresta S, Webb DR.

Repeated exposure to dengue virus elicits robust cross neutralizing antibodies against Zika virus in residents of Northeastern Thailand.

Hattakam S, Elong Ngono A, McCauley M, Shresta S, Yamabhai M.

Human FcRn expression and Type I Interferon signaling control Echovirus 11 pathogenesis in mice.

Wells AI, Grimes KA, Kim K, Branche E, Bakkenist CJ, DePas WH, Shresta S, Coyne CB.

Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.

Nair S, Mazzoccoli L, Jash A, Govero J, Bais SS, Hu T, Fontes-Garfias CR, Shan C, Okada H, Shresta S, Rich JN, Shi PY, Diamond MS, Chheda MG.

Whole genome sequencing of dengue virus serotype 2 from two clinical isolates and serological profile of dengue in the 2015-2016 Nepal outbreak.

Manandhar KD, McCauley M, Gupta BP, Kurmi R, Adhikari A, Nguyen AV, Elong Ngono A, Zompi S, Sessions OM, Shresta S.

Whole Genome Sequencing of Dengue Virus Serotype 2 from Two Clinical Isolates and AU3 AU2 Serological Profile of Dengue in the 2015–2016 Nepal Outbreak

Manandhar K, McCauley M, Gupta BP, Kurmi R, Adhikari A, Nguyen A, Ngono AE, Zompi S, Sessions O, Shresta S.

Targeting Endoplasmic Reticulum α-Glucosidase I With a Single-Dose Iminosugar Treatment Protects Against Lethal Influenza and Dengue Virus Infections

Warfield KL, Alonzi DS, Hill JC, Caputo AT, Roversi P, Kiappes JL, Sheets N, Duchars M, Dwek RA, Biggins J, Barnard D, Shresta S, Treston AM, Zitzmann N.

CD8+ T cells mediate protection against Zika virus induced by anNS3-based vaccine

Ngono AE, Syed T, Nguyen A, Regla-Nava J, Susantono M, Spasova D, Aguilar A, West M, Sparks J, Gonzalez A, Branche E, DeHart JL, Vega JB, Karmali PP, Chivukula P, Kamrud K, Aliahmad P, Wang N, Shresta S.